ActoGeniX N.V.

📍 Zwijnaarde, Belgium👥 5 employees💰 Last funded 2007
Biotechnology Research🌐 ActoGeniX.com
Website LinkedIn
ActoGeniX is a biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs; ActoBiotics™. ActoBiotics™ are created using TopAct™, ActoGeniX’s versatile and proprietary technology platform. They can be orally administered and target receptors and pathways in gastrointestinal tissues. This novel class of biopharmaceuticals has the potential to treat a broad range of severe diseases. With several ActoBiotics™ in various stages of clinical and preclinical development, ActoGeniX’s initial focus is on areas with unmet need in gastrointestinal, immunological and metabolic diseases.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in ActoGeniX N.V.?
ActoGeniX N.V. has 1 investors on record on gritt.io.
When did ActoGeniX N.V. last raise funding?
The most recent investment in ActoGeniX N.V. recorded on gritt.io was in 2007.
What industry is ActoGeniX N.V. in?
ActoGeniX N.V. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ActoGeniX N.V. based?
ActoGeniX N.V. is headquartered in Zwijnaarde, Belgium.